 SAFETY AND EFFICACY STUDY OF MFOLFOX6 PANITUMUMAB COMBINATION THERAPY AND 5-FULV PANITUMUMAB COMBINATION THERAPY IN PATIENTS WITH CHEMOTHERAPY-NAÏVE UNRESECTABLE ADVANCED RECURRENT COLORECTAL CARCINOMA: 